Font, G.; Walet-Balieu, M.-L.; Petit, M.; Burel, C.; Maho-Vaillant, M.; Hébert, V.; Chan, P.; Fréret, M.; Boyer, O.; Joly, P.;
et al. IgG N-glycosylation from Patients with Pemphigus Treated with Rituximab. Biomedicines 2022, 10, 1774.
https://doi.org/10.3390/biomedicines10081774
AMA Style
Font G, Walet-Balieu M-L, Petit M, Burel C, Maho-Vaillant M, Hébert V, Chan P, Fréret M, Boyer O, Joly P,
et al. IgG N-glycosylation from Patients with Pemphigus Treated with Rituximab. Biomedicines. 2022; 10(8):1774.
https://doi.org/10.3390/biomedicines10081774
Chicago/Turabian Style
Font, Guillaume, Marie-Laure Walet-Balieu, Marie Petit, Carole Burel, Maud Maho-Vaillant, Vivien Hébert, Philippe Chan, Manuel Fréret, Olivier Boyer, Pascal Joly,
and et al. 2022. "IgG N-glycosylation from Patients with Pemphigus Treated with Rituximab" Biomedicines 10, no. 8: 1774.
https://doi.org/10.3390/biomedicines10081774
APA Style
Font, G., Walet-Balieu, M. -L., Petit, M., Burel, C., Maho-Vaillant, M., Hébert, V., Chan, P., Fréret, M., Boyer, O., Joly, P., Calbo, S., Bardor, M., & Golinski, M. -L.
(2022). IgG N-glycosylation from Patients with Pemphigus Treated with Rituximab. Biomedicines, 10(8), 1774.
https://doi.org/10.3390/biomedicines10081774